Your browser doesn't support javascript.
loading
Single-catheter approach to pulmonary vein reisolation in selected patients : Data from a prospective registry.
Lauschke, J; Schneider, R; Wissmann, J; Tischer, T; Bänsch, D.
  • Lauschke J; Department of Cardiology, University Medical Center, Ernst-Heydemann-Str. 6, 18059, Rostock, Germany. joerg.lauschke@uni-rostock.de.
  • Schneider R; Department of Cardiology, University Medical Center, Ernst-Heydemann-Str. 6, 18059, Rostock, Germany.
  • Wissmann J; Department of Cardiology, University Medical Center, Ernst-Heydemann-Str. 6, 18059, Rostock, Germany.
  • Tischer T; Department of Cardiology, University Medical Center, Ernst-Heydemann-Str. 6, 18059, Rostock, Germany.
  • Bänsch D; Department of Cardiology, University Medical Center, Ernst-Heydemann-Str. 6, 18059, Rostock, Germany.
Herz ; 41(7): 625-629, 2016 Nov.
Article en En | MEDLINE | ID: mdl-26883899
ABSTRACT

BACKGROUND:

In addition to different types of single-tip ablation catheters for pulmonary vein (PV) reisolation, a newly developed circular mapping and ablation catheter (nMARQ®) has been available since 2013 and is currently used only in initial PV isolation procedures. In this prospective registry we present feasibility and efficacy data for PV reisolation procedures with a single-catheter approach (nMARQ®) compared with a standard approach using a single-tip ablation catheter and a circular mapping catheter.

METHODS:

We included 35 carefully selected patients in this prospective registry and assigned them in a 21 ratio to undergo either PV reisolation with a single-tip ablation catheter together with a steerable circular mapping catheter (group 1) or with the nMARQ®catheter only (group 2). The recurrence rate was calculated for atrial tachyarrhythmias with a duration of > 30 s during a mean follow-up of 12.7 months.

RESULTS:

Reisolation of all PVs was achieved in all patients of both groups. In group 2, all gaps could be correctly identified with the nMARQ® catheter. PV isolation was clearly visible on the nMARQ® catheter in all targeted veins. With the nMARQ® catheter the ablation time decreased significantly (6.3 ± 3.0 vs. 18.6 ± 13.9 min, p < 0.05). The recurrence rate of atrial fibrillation did not differ significantly between the two groups (37.5 vs. 45.5 %, p = 0.66).

CONCLUSION:

In selected patients, a complete PV reisolation procedure is feasible with a singular circular mapping and ablation catheter. The 12-months success rate is comparable to a classic approach with a combination of a single-tip ablation catheter and a circular mapping catheter.
Asunto(s)
Palabras clave
Search on Google
Banco de datos: MEDLINE Asunto principal: Venas Pulmonares / Fibrilación Atrial / Sistema de Registros / Ablación por Catéter Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2016 Tipo del documento: Article
Search on Google
Banco de datos: MEDLINE Asunto principal: Venas Pulmonares / Fibrilación Atrial / Sistema de Registros / Ablación por Catéter Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2016 Tipo del documento: Article